Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/1999
09/01/1999EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor
09/01/1999EP0828497B1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives
09/01/1999EP0700301B1 Peptides and compounds that bind to elam-1
09/01/1999EP0625160B1 Leukinferon preparation
09/01/1999CN1227611A Isolated nucleic acid molecules which are members of the MAGE-B family and use thereof
09/01/1999CN1227603A TIE-2 receptor ligands (TIE ligand-3; TIE ligand-4) and their uses
09/01/1999CN1227559A Highly lipophilic camptothecin derivatives
09/01/1999CN1227554A Substituted 6,5-hetero-bicyclic derivatives
09/01/1999CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
09/01/1999CN1227225A Thiazole derivatives
09/01/1999CN1227119A Medicine for curing hystere myoma
09/01/1999CN1227105A Anti-cancer medicine and its preparing method
08/1999
08/31/1999US5945577 Nuclear transfer units for cells
08/31/1999US5945440 Indolocarbazole imides and the use thereof
08/31/1999US5945439 Method for destroying or inhibiting growth of unwanted cells or tissues
08/31/1999US5945411 Chemoprevention of metachronous adenomatous colorectal polyps
08/31/1999US5945410 Administered to treat postmanopausal osteoporosis, low bone turnover osteoporosis, osteomalacia and renal osteodystrophy
08/31/1999US5945406 Anticancer agents; treatment for metastatic liver cancer, fungal infections, psoriasis; used in manufacture of drugsto prevent cell division
08/31/1999US5945403 Angiostatin fragments and method of use
08/31/1999US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent
08/31/1999US5945315 Isolating compound from culture of gsv224 nostoc species; antiproliferative agent for drug resistant cells
08/31/1999US5945310 DNA encoding members of the IL-1 family, IL-1 delta
08/31/1999US5945308 Polynucleotide
08/31/1999US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases
08/31/1999US5945300 Polypeptides with dna(rna) encoding and genetic engineering
08/31/1999US5945122 Liposomes containing a cisplatin compound
08/31/1999US5945100 Tumor delivery vehicles
08/31/1999CA2167382C Novel fused indan derivative and pharmaceutically acceptable salt thereof
08/31/1999CA2149765C Sequence-specific binding polymers for duplex nucleic acids
08/31/1999CA2145835C Hydroxamic acid derivatives with tricyclic substitution
08/31/1999CA2069374C Synthesis of 19-nor vitamin d compounds
08/26/1999WO1999042839A2 Treating cancer
08/26/1999WO1999042837A1 Treating cancer
08/26/1999WO1999042836A1 Treating cancer
08/26/1999WO1999042835A1 Treating cancer
08/26/1999WO1999042834A2 Treating cancer
08/26/1999WO1999042828A2 Treating cancer
08/26/1999WO1999042821A2 Treating cancer
08/26/1999WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR
08/26/1999WO1999042602A2 Fermentative preparation process for cytostatics and crystal forms thereof
08/26/1999WO1999042593A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
08/26/1999WO1999042584A1 Apoptosis inducing molecule ii and methods of use
08/26/1999WO1999042579A2 Caf1-related protein
08/26/1999WO1999042568A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
08/26/1999WO1999042564A2 Apoptotic cell-mediated antigen presentation to dendritic cells
08/26/1999WO1999042486A1 Method of producing mouse and human endostatin
08/26/1999WO1999042485A1 Mucilage, a g-protein-coupled receptor
08/26/1999WO1999042481A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
08/26/1999WO1999042477A2 Transporter protein for saccharide-coupled medicaments
08/26/1999WO1999042453A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
08/26/1999WO1999042445A1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
08/26/1999WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
08/26/1999WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
08/26/1999WO1999042429A1 Antitumor agents
08/26/1999WO1999042140A1 Detector molecule for use in a method for detecting and surgically removing lymphoid tissue involved in tumor progression
08/26/1999WO1999042137A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
08/26/1999WO1999042128A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999WO1999042125A1 Pharmaceutical formulation of a didemnin compound
08/26/1999WO1999042121A1 Modified heat shock protein-antigenic peptide complex
08/26/1999WO1999042113A1 Composition and method for the treatment of bladder cancer
08/26/1999WO1999042102A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
08/26/1999WO1999042090A2 Treating cancer
08/26/1999WO1999042089A2 Use of thiadiazolo[4,3-a]pyridine derivatives
08/26/1999WO1999041985A1 P53-dependent secretion of growth inhibitory factors
08/26/1999WO1999031060A3 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants
08/26/1999WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
08/26/1999WO1999026609A3 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
08/26/1999WO1999025375A3 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES
08/26/1999WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
08/26/1999WO1999004265A3 Cancer associated nucleic acids and polypeptides
08/26/1999WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999WO1998004693A3 Secreted proteins and polynucleotides encoding them
08/26/1999DE19909251A1 Agents for treating human diseases, particularly cancer, modulate interaction of beta-catenin with transcription factors or tumor suppressor gene products
08/26/1999DE19835633C1 Animal or human tumor cells which express immunoglobulins
08/26/1999DE19811326C1 Preparation of medicaments for the treatment of tumor diseases and for immuno-suppression
08/26/1999DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors
08/26/1999DE19807389A1 New monoclonal antibodies, useful for diagnosing gynecological cancers
08/26/1999CA2357015A1 Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof
08/26/1999CA2321958A1 Method of producing mouse and human endostatin
08/26/1999CA2321482A1 Treating cancer
08/26/1999CA2321481A1 Treating cancer
08/26/1999CA2321480A1 Treating cancer
08/26/1999CA2321479A1 Treating cancer
08/26/1999CA2321467A1 Treating cancer
08/26/1999CA2321458A1 Treating cancer
08/26/1999CA2321438A1 Treating cancer
08/26/1999CA2321296A1 Composition and method for the treatment of bladder cancer
08/26/1999CA2321222A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999CA2321186A1 Apoptosis inducing molecule ii and methods of use
08/26/1999CA2321182A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
08/26/1999CA2321101A1 Modified heat shock protein-antigenic peptide complex
08/26/1999CA2320808A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999CA2320632A1 Caf1-related protein
08/26/1999CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
08/26/1999CA2318818A1 Fermentative preparation process for cytostatics and crystal forms thereof
08/26/1999CA2318237A1 Use of thiadiazolo[4,3-a]pyridine derivatives
08/25/1999EP0937777A2 GABA receptors and their uses
08/25/1999EP0937726A1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
08/25/1999EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors
1 ... 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 ... 2211